To help producers and veterinarians reach optimal pig performance with greater convenience, Boehringer Ingelheim Vetmedica Inc. (BIVI) now offers a 250-dose option for the 3FLEX trivalent vaccine.

3FLEX continues to provide customized control against porcine circovirus Type 2 (PCV2), porcine reproductive and respiratory syndrome (PRRS) and Mycoplasma hyopneumoniae, by combining the protection of three leading products — Ingelvac PRRS MLV, Ingelvac CircoFLEX and Ingelvac MycoFLEX — in one application.

"Extensive research studies show lack of interference between antigens in 3FLEX, which means we can confidently mix and administer these three single-dose products within 3FLEX and expect consistent safety and efficacy," BIVI technical manager Dr. Eduardo Fano said. "This gives pigs a high level of disease protection to reduce incidences of co-infections and increase performance."

He added that new 250-dose units add to the convenience of using the vaccine for customers, especially those with larger systems. A 50-dose option is also available.

New mixing procedures

BIVI is also updating the packaging of existing product presentations to streamline the mixing and administration process of the FLEX Family of swine vaccines. The new mixing process will provide a consistent method in mixing and administering the entire FLEX Family of swine vaccines.

This process will be introduced with the launch of the new 250-dose presentations of 3FLEX and Ingelvac PRRS MLV, which includes:

• New vented transfer spike allowing for easy, no-mess mixing.

• New packaging changes the mixing bottle from glass to plastic, benefiting the environment and reducing packaging waste.

• New FLEX Family Mixing Guide instructions.

• New SKUs: Ingelvac PRRS MLV — 118504 (10 dose), 118378 (50 dose), 115903 (250 dose); 3FLEX — 118377 (50 dose), 117097 (250 dose).

The BIVI FLEX Family of swine vaccines provides the choice of five respiratory vaccines that allow customized control of major respiratory diseases in your swine herd. For more information on the FLEX Family of products, and other BIVI swine vaccines, ask a veterinarian, call BIVI at (800) 325-9167 or visit www.bi-vetmedica.com/swine.

BIVI is the fifth largest animal health company in the U.S. and produces innovative vaccine and pharmaceutical products for the prevention and treatment of diseases in the swine, cattle, equine and companion animal markets. BIVI is the U.S. subsidiary of the global Boehringer Ingelheim Animal Health GmbH.